- United States
- /
- Professional Services
- /
- NasdaqGS:EXPO
Exponent Full Year 2024 Earnings: EPS Beats Expectations
Exponent (NASDAQ:EXPO) Full Year 2024 Results
Key Financial Results
- Revenue: US$518.5m (up 4.3% from FY 2023).
- Net income: US$109.0m (up 8.6% from FY 2023).
- Profit margin: 21% (in line with FY 2023).
- EPS: US$2.13 (up from US$1.96 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Exponent EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.3%.
Looking ahead, revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Professional Services industry in the US.
Performance of the American Professional Services industry.
The company's shares are down 2.2% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on Exponent's balance sheet.
If you're looking to trade Exponent, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentValuation is complex, but we're here to simplify it.
Discover if Exponent might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:EXPO
Exponent
Operates as a science and engineering consulting company in the United States and internationally.
Flawless balance sheet with solid track record and pays a dividend.